Skip to main content
SpringerLink
Log in

Natural history of systemic reactions and risk factors in children and adults with Hymenoptera venom allergy

  • Übersicht
  • Children and adults with Hymenoptera venom allergy
  • Published:
Allergo Journal Aims and scope Submit manuscript

Abstract

Purpose: Stings by Hymenoptera usually cause just local reactions. However, in some cases, they can induce systemic symptoms and even fatal reactions. The natural history and the risk factors of severe systemic reactions are presented in this review.

Methods: Both the natural history and risk factors of systemic reactions due to insect stings are unraveled. This publication is based on a selective literature search in PubMed, Web of Science, and EMBASE (until 30 July 2019). Recent publications about insect venom allergy in English journals were analyzed. This literature search included original and review articles and relevant abstracts of allergy congresses in English.

Results: Risk factors are classified as follows: (1) patient-related, (2) allergen-related and (3) reaction-related and also risk factor associated to venom immunotherapy (VIT) are considered. Due to the scarcity of data about the suitability of premedication before and during VIT, a succinct table gathering available premedication invites further investigation.

Conclusions: There is limited evidence with regard to the natural history of HVA both in adults and in children. Several risk factors may influence the natural history of HVA, namely patient-related, allergen-related and reaction-related. Other factors are inherent to the use of venom immunotherapy (VIT).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sturm GJ, Varga EM, Roberts G, Mosbech H, Bilò MB, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: hymenopteravenomallergy. Allergy 2018;73:744-64

    Article  PubMed  Google Scholar 

  2. Pesek RD, Lockey RF. Treatment of hymenoptera venom allergy: an update. Curr Opin Allergy Clin Immunol 2014;14:340-8

    Article  CAS  PubMed  Google Scholar 

  3. Ollert M, Blank S. Anaphylaxis to insect venom allergens: role of molecular diagnosis. Curr Allergy Asthma Rep 2015;15:2

  4. Elberink JN, Dubois AE. Quality of life in insect venom allergic patients. Curr Opin Allergy Clin Immunol 2003;3:287-93

  5. Alfaya T, Vega A, Domínguez-Noche C, Ruíz B, Marques L, Sánchez-Morillas L. Longitudinal validation of the Spanish versionofthehealth-relatedquality of lifequestionnaire for hymenoptera venom allergy (HRQLHA). J Investig Allergol ClinImmunol 2015;25:426-30

  6. Armisén M, Guspi R, Alfaya T, Crus S, Fernández S, Domínguez-Noche C, et al. Cross-sectional validation of a quality of life questionnaire in Spanish for patients allergic to hymenoptera venom. J Investig Allergol Clin Immunol 2015;25:176-82

  7. Antolín-Amérigo D, Ruiz-León B, Boni E, Alfaya-Arias T, Álvarez-Mon M, Barbarroja-Escudero J, et al. Component-resolved diagnosis in hymenoptera allergy. Allergol Immunopathol 2018;46:253-62

    Article  PubMed  Google Scholar 

  8. Alfaya Arias T, Soriano Gómis V, Soto MeraT, Vega Castro A, Vega Gutiérrez JM, Alonso Llamazares A, et al. Key issues in hymenoptera venom allergy: an update. J Investig Allergol Clin Immunol 2017;27:19-31

    Article  CAS  PubMed  Google Scholar 

  9. Lange J, Cichocka-Jarosz E, Marczak H, Krauze A, Tarczon I, ´Swiebocka E, et al. Natural history of hymenoptera venom allergy in children not treated with immunotherapy. Ann Allergy Asthma Immunol 2016;116:225-9

    Article  Google Scholar 

  10. Worm M, Francuzik W, Renaudin JM, Bilò MB, Cardona V, Scherer Hofmeier K, et al. Factors increasing the risk for a severe reaction in anaphylaxis: ananalysis of data from the European anaphylaxis registry. Allergy 2018;73:1322-30

    Article  CAS  PubMed  Google Scholar 

  11. Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender, difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008;63:1418-27

    Article  CAS  PubMed  Google Scholar 

  12. Ruëff F, Przybilla B, Bilò MB, Müller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline serumtryptase — a study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity. J Allergy Clin Immunol 2009;124:1047-54

    Article  CAS  Google Scholar 

  13. Bonadonna P, Scaffidi L. Hymenoptera anaphylaxis as a clonal mast cell disorder. Immunol Allergy Clin North Am 2018;38:455-68

    Article  PubMed  Google Scholar 

  14. Alvarez-Twose I, Matito A. Mastocytosis presenting as insect anaphylaxis: gender differences and natural history. Curr Opin Allergy Clin Immunol 2019;19:1468-74

    Article  CAS  PubMed  Google Scholar 

  15. González de Olano D, de la Hoz Caballer B, Núñez López R, Sánchez Muñoz L, Cuevas Agustín M, Diéguez MC, et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). ClinExpAllergy 2007;37:1547-55

  16. Bonadonna P, Zanotti R, Müller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol 2010;10:347-53

    Article  CAS  PubMed  Google Scholar 

  17. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al. Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009;123:680-6

    Article  CAS  Google Scholar 

  18. Vazquez-Revuelta P, Gonzalez-de-Olano D. Prevalence of clonal mast cell disorders in patients presenting with hymenoptera venom anaphylaxis might be higher than expected. J Investig Allergol Clin Immunol 2018;28:193-4

    Article  PubMed  Google Scholar 

  19. Alvarez-Twose I, Zanotti R, González-de-Olano D, Bonadonna P, Vega A, Matito A, et al. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect induced anaphylaxis shows unique features versus other indolent SM. J Allergy Clin Immunol 2014;133:520-8

    Article  Google Scholar 

  20. Zanotti R, Lombardo C, Passalacqua G, Caimmi C, Bonifacio M, De Matteis G, et al. Clonal mast cell disorders in patients with severe hymenoptera venom allergy and normal serum tryptase levels. J Allergy Clin Immunol 2015;136:135-9

    Article  CAS  Google Scholar 

  21. Vos BJPR, van Anrooij B, van Doormaal JJ, Dubois AEJ, Oude Elberink JNG. Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of atrisk patients. J Allergy Clin Immunol Pract 2017;5:1264-71

    Article  PubMed  Google Scholar 

  22. Michel J, Brockow K, Darsow U, Ring J,Schmidt-Weber CB, Grunwald T, et al. Added sensitivity of component resolved diagnosis in hymenoptera venom-allergic patients with elevated serum tryptase and/or mastocytosis. Allergy 2016;71:651-60

    Article  CAS  PubMed  Google Scholar 

  23. Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serumtryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. ClinExpAllergy 2003;33:1216-20

  24. Rueff F, Placzek M, Przybilla B. Mastocytosis and hymenopteravenomallergy. Curr Opin Allergy Clin Immunol 2006;6:284-8

  25. Gonzalez-de-Olano D, Alvarez-Twose I, Vega A, Orfao A, Escribano L. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis. Immunotherapy. 2011;3:637-51

    Article  PubMed  CAS  Google Scholar 

  26. Bonadonna P, Gonzalez-de-Olano D, Zanotti R, Riccio A, De FL, Lombardo C, et al. Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. J Allergy Clin Immunol Pract 2013;1:474-8

  27. Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, et al. Predictors of side effects during the buildup phase of venom immunotherapy for hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol 2010;126:105-111.e5

    Article  CAS  Google Scholar 

  28. Bonadonna P, Zanotti R, Pagani M, Bonifacio M, Scaffidi L, Olivieri E, et al. Anaphylactic reactions after discontinuation of hymenoptera venom immunotherapy: a clonal mast cell disorder should be suspected. J Allergy Clin Immunol Pract 2018;6:1368-72

    Article  PubMed  Google Scholar 

  29. Alvarez-Twose I, Gonzalez de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, et al. Clinical, biological and molecular characteristics of systemic mast cell disorders presenting with severe mediator-related symptoms. J Allergy Clin Immunol 2010;125:1269-78

  30. Stoevesandt J, Sturm GJ, Bonadonna P, Oude Elberink JNG, Trautmann A. Riskfactors and indicators of severe systemic insect sting reactions. Allergy 2019; https://doi.org/10.1111/all.13945

    Article  PubMed  Google Scholar 

  31. Arzt-Gradwohl L, Schrautzer C, Laipold K, Herzog SA, Stoevesandt J, Trautmann A, et al. No effect of antihypertensive drugs on severity of anaphylaxis and side-effects during venom immunotherapy. European academy of allergology and clinical immunology annual congress; 2019 June 1-5; Lisbon. Allergy 2019;74:233

  32. Matricardi PM, Bockelbrink A, Grüber C, Keil T, Hamelmann E, Wahn U, et al. Longitudinal trends of total and allergen-specific IgE throughout childhood. Allergy 2009;64:1093-8

    Article  CAS  PubMed  Google Scholar 

  33. Guan K, Li LS, Yin J. Use of sIgE/T-IgE in predicting systemic reactions: retrospective analysis of 54 honeybee venom allergy cases in North China. Chin Med J (Engl) 2016;129:2091-5

    Article  PubMed  PubMed Central  Google Scholar 

  34. Hamilton RG, MacGlashan DW Jr, Saini SS. IgE antibody specific activity in human allergic disease. Immunol Res 2010;47:273-84

    Article  CAS  PubMed  Google Scholar 

  35. Arzt L, Bokanovic D, Schrautzer C, Laipold K, Möbs C, PfütznerW, et al. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects. Allergy 2018;73:1223-31

    Article  PubMed  CAS  Google Scholar 

  36. Sturm GJ, Kranzelbinder B, Schuster C, Sturm EM, Bokanovic D, Vollmann J, et al. Sensitization to hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol 2014;133:1635-43

    Article  CAS  Google Scholar 

  37. Golden DBK, Demain J, Freeman T, Graft D, Tankersley M, Tracy J, et al. Stinging insect hypersensitivity. Ann Allergy Asthma Immunol 2017;118:28-54

    Article  Google Scholar 

  38. Bilo MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy 2009;39:1467-76

    Article  Google Scholar 

  39. Brown TC, Tankersley MS. The sting of the honeybee: an allergic perspective. Ann Allergy Asthma Immunol 2011;107:463-70. quiz471

    Article  CAS  Google Scholar 

  40. Muller UR. Bee venom allergy in beekeepers and their family members. Curr Opin Allergy Clin Immunol 2005;5:343-7

    Article  PubMed  Google Scholar 

  41. Golden DB, Breisch NL, Hamilton RG, Guralnick MW, Greene A, Craig TJ, et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol 2006;117:670-5

    Article  Google Scholar 

  42. Fleming JT, Clark S, Camargo CA Jr., Rudders SA. Early treatment of food induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract 2015;3:57-62

    Article  PubMed  Google Scholar 

  43. Stoevesandt J, Hain J, Kerstan A, Trautmann A. Over- and underestimated parameters in severe hymenoptera venom induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. J Allergy Clin Immunol 2012;130:698-704

    Article  Google Scholar 

  44. Arzt L, Bokanovic D, Schwarz I, Schrautzer C, Massone C, Horn M, et al. Hymenoptera stings in the head region induce impressive, but not severe sting reactions. Allergy 2016;71:1632-4

    Article  CAS  PubMed  Google Scholar 

  45. Solley GO. Stinging and biting insect allergy: an Australian experience. Ann Allergy Asthma Immunol 2004;93:53-537

    Article  Google Scholar 

  46. Ruiz B, Serrano P, Verdú M, Moreno C. Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy. Ann Allergy Asthma Immunol 2015;114:350-2

    Article  CAS  Google Scholar 

  47. Bilò M, Pravettoni V, Bignardi D, Bonadonna P, Mauro M, Novembre E, et al. Hymenoptera venom allergy: management of children and adults in clinical practice. J Investig Allergol Clin Immunol 2019;29:180-205

    Article  PubMed  CAS  Google Scholar 

  48. Köhler J, Blank S, Müller S, Bantleon F, Frick M, Huss-Marp J, et al. Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol 2014;133:1383-9

    Article  CAS  Google Scholar 

  49. Blank S, Seismann H, Michel Y, McIntyre M, Cifuentes L, Braren I, et al. Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts. Allergy 2011;66:1322-9

    Article  CAS  PubMed  Google Scholar 

  50. Lerch E, Müller UR. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol 1998;101:606-12

  51. Hockenhull JE, lremeli M, Cherry MG, Mahon J, LaiM, Darroch J, et al. A systematic review of the clinical effectiveness and cost-effectiveness of pharmalgen for the treatment of bee and wasp venom allergy. Health Technol Assess 2012;16:1-110

  52. Catalá M, Gómez A, Ollo B, Gurpegui M, Talens M. Safety of hymenopteran venoms immunotherapy in a cluster schedule. A nursing perspective. An Sist Sanit Navar 2009;32:409-12

  53. Wöhrl S, Gamper S, Hemmer W, Heinze G, Stingl G, Kinaciyan T. Premedication with montelukast reduces local reactions of allergen immunotherapy. Int Arch Allergy Immunol. 2007;144:137-42

    Article  PubMed  CAS  Google Scholar 

  54. Müller U, Hari Y, Berchtold E. Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 2001;107:81-6

    Article  Google Scholar 

  55. Arseneau AM, Nesselroad TD, Dietrich JJ, Moore LM, Nguyen S, Hagan LL, et al. A 1-day imported fire ant rush immunotherapy schedule with and without premedication. Ann Allergy Asthma Immunol 2013;111:562-6

    Article  Google Scholar 

  56. González-de-Olano D, Padial-Vilche MA, Núñez-Acevedo B, de-Calzada-Bustingorri MP, de-Andrés-Martín A, Caldas C, et al. Usefulness of omalizumab and sting challenge test in hymenoptera venom allergy and mastocytosis. J Investig Allergol Clin Immunol 2019;29:318-20

    Article  PubMed  Google Scholar 

  57. Droitcourt C, Ponvert C, Dupuy A, Scheinmann P, Abou-Taam R, de Blic J, et al. Efficacy of a short pretreatment with omalizumab in children with anaphylaxis to hymenoptera venom immunotherapy: a report of three cases. Allergol Int 2019;68:268-9

    Article  PubMed  Google Scholar 

  58. Galera C, Soohun N, Zankar N, Caimmi S, Gallen C, Demoly P. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab. J Investig Allergol Clin Immunol 2009;19:225-9

  59. Stretz E, Oppel EM, Räwer HC, Chatelain R, Mastnik S, Przybilla B, et al. Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose. Clin Exp Allergy 2017;47:1631-9

    Article  CAS  Google Scholar 

  60. Clifford D, Ni Chaoimh C, Stanley E, O'B Hourihane J. A longitudinal study of hymenoptera stings in preschool children. Pediatr Allergy Immunol 2019;30:93-8

    Article  PubMed  Google Scholar 

  61. Cichocka-Jarosz E, Brzyski P, Tarczo´ n I, Jedynak-Wasowicz U, Tomasik T, Lis G. Quality of life in parents of children and adolescents after systemic sting reactions. Ann Agric Environ Med 2019;26:315-21

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partially presented as a lecture in the EAACI Allergy School on Insect Venom Allergy and Mastocytosis held in Groningen, The Netherlands, April 11-13, 2019 and is part of the work of the Insect Venom Hypersensitivity Committee of the Spanish Society of Allergology and Clinical Immunology (SEAIC).

Author information

Authors and Affiliations

  1. Instituto Ramón y Cajal Investigación Sanitari, Madrid, Spanien

    Darío Antolín-Amérigo

  2. Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spanien

    Berta Ruiz-León

  3. Servicio de Alergia, Hospital Universitario de Guadalajara, Guadalajara, Spanien

    A. Vega-Castro

  4. Instituto de Salud Carlos III, Madrid, Spanien

    Belén de la Hoz Caballer

Authors
  1. Darío Antolín-Amérigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Berta Ruiz-León
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Vega-Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Belén de la Hoz Caballer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Darío Antolín-Amérigo.

Ethics declarations

D. Antolín Amérigo has received fees from talks from ALK and Allergy Therapeutics outside the work; A. Vega-Castro has received fees from lectures from ALK, Diater and Leti outside the work; B. Ruiz León has received fees from lectures from ALK outside the work. Belén de la Hoz declares no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antolín-Amérigo, D., Ruiz-León, B., Vega-Castro, A. et al. Natural history of systemic reactions and risk factors in children and adults with Hymenoptera venom allergy. Allergo J 29, 26–33 (2020). https://doi.org/10.1007/s15007-020-0745-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15007-020-0745-0

Keywords

Search

Navigation